Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
Open accessAbstract
Rationale Although psilocybin and dextromethorphan (DXM) are hallucinogens, they have different receptor mechanisms of action and have not been directly compared.Objective This study compared subjective, behavioral, and physiological effects of psilocybin and dextromethorphan under conditions that minimized expectancy effects.Methods Single, acute oral doses of psilocybin (10, 20, 30 mg/70 kg), DXM (400 mg/70 kg), and placebo were administered under double-blind conditions to 20 healthy participants with histories of hallucinogen use. Instructions to participants and staff minimized expectancy effects. Various subjective, behavioral, and physiological effects were assessed after drug administration.Results High doses of both drugs produced similar increases in participant ratings of peak overall drug effect strength, with similar times to maximal effect and time-course. Psilocybin produced orderly dose-related increases on most participant-rated subjective measures previously shown sensitive to hallucinogens. DXM produced increases on most of these same measures. However, the high dose of psilocybin produced significantly greater and more diverse visual effects than DXM including greater movement and more frequent, brighter, distinctive, and complex (including textured and kaleidoscopic) images and visions. Compared to DXM, psilocybin also produced significantly greater mystical-type and psychologically insightful experiences and greater absorption in music. In contrast, DXM produced larger effects than psilocybin on measures of disembodiment, nausea/emesis, and light-headedness. Both drugs increased systolic blood pressure, heart rate, and pupil dilation and decreased psychomotor performance and balance.Conclusions Psilocybin and DXM produced similar profiles of subjective experiences, with psilocybin producing relatively greater visual, mystical-type, insightful, and musical experiences, and DXM producing greater disembodiment.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This particular phenomenological quality seems unique to the serotonergic psychedelics-in a direct comparison between psilocybin and dextromethorphan (a non-serotonergic psychedelic) experiences, psilocybin produced greater visual, mystical-type, insightful, and musical experiences.
“This particular phenomenological quality seems unique to the serotonergic psychedelics—in a direct comparison between psilocybin and dextromethorphan (a non-serotonergic psychedelic) experiences, psilocybin produced ‘greater visual, mystical-type, insightful, and musical experiences’ (Carbonaro et al. 2018, 1).”
From Consciousness in active inference: Deep self-models, other minds, and the challenge of psychedelic-induced ego-dissolution (2021) · cites this paper as Carbonaro et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 61 · Cited by 133
Research works printed but not linked: 3
- Metzner R, Litwin G, Weil G (1965) The relation of expectation and mood to psilocybin reactions: A questionnaire study. Psychedelic Review 5: 3– 39
- Shulgin A, Shulgin A (1997) TiHKAL. Transform Press, Berkeley, CA
- Strassman R (2001) DMT: The spirit molecule. Park Street Press, Rochester, VA
- Authors
- Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Griffiths, Roland R.
- Venue
- Psychopharmacology
- Published
- 2017-11-07
- Volume
- 235
- Issue
- 2
- Pages
- 521-534
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC6645364
- OpenAlex
- W2767725891
- Cited by
- 133
- References
- 61
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 16 · 2023: 33 · 2022: 19 · 2021: 11 · 2020: 13 · 2019: 6 · 2018: 6
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA03889, T32 DA07209)
- National Institutes of Health (P30CA006973, UL1TR001079, S10OD020091)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- psilocybin, dextromethorphan, hallucinogens, subjective drug effects, visual hallucinations, mystical experience, disembodiment, nausea, pupil dilation, psychomotor performance, heart rate, blood pressure, dose-response relationship, expectancy effects
- MeSH terms
- Adult, Blood Pressure, Dextromethorphan, Dose-Response Relationship, Drug, Double-Blind Method, Female, Hallucinations, Hallucinogens, Heart Rate, Humans, Male, Music, Mysticism, Psilocybin, Surveys and Questionnaires, Substance-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review